US biotechnology company Moderna Inc, one of the two leading makers of mRNA vaccines for COVID-19, on Tuesday announced that it would establish four subsidiaries in Taiwan, Hong Kong, Malaysia and Singapore to support delivery of its vaccines and therapeutics.
The subsidiary in Taiwan is expected to be set up by the end of this year, Moderna told Chinese-language media, adding that it would recruit local talent and collaborate with local hospitals on clinical trials.
Moderna has signed a contract with Taiwan to offer 20 million COVID-19 vaccine and booster doses this year, and another 15 million next year, the company said in a statement.
Photo: Reuters
In Taiwan, its COVID-19 vaccine has been approved for people aged 18 or older, while its booster shots can be given to those who had their second dose five months prior, it said.
Moderna provides Taiwan with its mRNA-1273 vaccine, which targets variants of SARS-CoV-2, and it is developing a next-generation vaccine that it expects to launch in the second half of this year, pending regulatory approval, Moderna senior vice president Patrick Bergstedt said in an interview with the Chinese-language United Daily News.
“This is why we set up a subsidiary in Taiwan — we hope to cooperate with local hospitals and regulators directly so that we could provide our vaccine,” United Daily News quoted Bergstedt as saying.
More studies are required to determine whether booster shots should be given once every six months or once a year, he said.
Moderna did not say whether it would consider manufacturing its COVID-19 vaccine in Taiwan, but the Central News Agency (CNA) yesterday reported that the government is attempting to arrange a technology transfer for the vaccine.
To facilitate a transfer, the government plans to set up a new company in which the National Development Fund would hold a stake of less than 49 percent and the remaining shares would belong to private companies, CNA reported.
South Korea’s Samsung Biologics Co has since May last year been assigned the fill and finish manufacturing task for Moderna’s COVID-19 vaccines, corporate data showed.
Minister of Health and Welfare Chen Shih-chung (陳時中) last year told lawmakers that the US is protective of its mRNA technology, so there would be a higher chance of Taiwan participating in the back-end manufacturing processes, such as fill and finish — the process of filling vials with vaccine and finishing the process of packaging the medicine — than in core manufacturing.
However, Taiwan would strive to transfer the technology, he said.
Asked whether Moderna’s decision to set up a branch in Taiwan could lead to the company’s vaccines being produced in Taiwan or other types of cooperation, Chen yesterday said that the ministry does not know the company’s development plans, but welcomes it to Taiwan and would not exclude the possibility of further cooperation.
Moderna said that the addition of the four subsidiaries comes as it continues to scale up the manufacturing and distribution of its COVID-19 vaccine, and future mRNA vaccines and therapeutics.
The Asia-Pacific region represents an integral part of Moderna’s business, with established subsidiaries in Australia, South Korea and Japan, it said.
Additional reporting by Lee I-chia
LONG FLIGHT: The jets would be flown by US pilots, with Taiwanese copilots in the two-seat F-16D variant to help familiarize them with the aircraft, the source said The US is expected to fly 10 Lockheed Martin F-16C/D Block 70/72 jets to Taiwan over the coming months to fulfill a long-awaited order of 66 aircraft, a defense official said yesterday. Word that the first batch of the jets would be delivered soon was welcome news to Taiwan, which has become concerned about delays in the delivery of US arms amid rising military tensions with China. Speaking on condition of anonymity, the official said the initial tranche of the nation’s F-16s are rolling off assembly lines in the US and would be flown under their own power to Taiwan by way
OBJECTS AT SEA: Satellites with synthetic-aperture radar could aid in the detection of small Chinese boats attempting to illegally enter Taiwan, the space agency head said Taiwan aims to send the nation’s first low Earth orbit (LEO) satellite into space in 2027, while the first Formosat-8 and Formosat-9 spacecraft are to be launched in October and 2028 respectively, the National Science and Technology Council said yesterday. The council laid out its space development plan in a report reviewed by members of the legislature’s Education and Culture Committee. Six LEO satellites would be produced in the initial phase, with the first one, the B5G-1A, scheduled to be launched in 2027, the council said in the report. Regarding the second satellite, the B5G-1B, the government plans to work with private contractors
MISSION: The Indo-Pacific region is ‘the priority theater,’ where the task of deterrence extends across the entire region, including Taiwan, the US Pacific Fleet commander said The US Navy’s “mission of deterrence” in the Indo-Pacific theater applies to Taiwan, Pacific Fleet Commander Admiral Stephen Koehler told the South China Sea Conference on Tuesday. The conference, organized by the Center for Strategic and International Studies (CSIS), is an international platform for senior officials and experts from countries with security interests in the region. “The Pacific Fleet’s mission is to deter aggression across the Western Pacific, together with our allies and partners, and to prevail in combat if necessary, Koehler said in the event’s keynote speech. “That mission of deterrence applies regionwide — including the South China Sea and Taiwan,” he
‘NARWHAL’: The indigenous submarine completed its harbor acceptance test recently and is now under heavy guard as it undergoes tests in open waters, a source said The Hai Kun (海鯤), the nation’s first indigenous defense submarine, yesterday began sea trials, sailing out of the Port of Kaohsiung, a military source said. Also known as the “Narwhal,” the vessel departed from CSBC Corp, Taiwan’s (台灣國際造船) shipyard at about 8am, where it had been docked. More than 10 technicians and military personnel were on deck, with several others standing atop the sail. After recently completing its harbor acceptance test, the vessel has started a series of sea-based trials, including tests of its propulsion and navigational systems, while partially surfaced, the source said. The Hai Kun underwent tests in the port from
RSS